(Bloomberg) — AstraZeneca Plc shares plunged in London, erasing about £14 billion ($18 billion) of market value, amid escalating concerns over a Chinese probe into the UK drugmaker. Most Read from Bloomberg Traders cited a report from the Yicai news service released earlier in the day, with the stock’s losses snowballing during afternoon trading. AstraZeneca…
(Reuters) – AstraZeneca shares recorded their biggest one-day drop since March 2020 on Tuesday following a report that dozens of senior executives at its China unit could be implicated in the largest insurance fraud case in the country’s pharma sector in years. The investigation by Chinese authorities has now expanded to include the public security…
Chinese internet regulators are removing social media accounts that use fake information to hype the country’s military strength, including false reports of “cyberwarfare” in the South China Sea. A sample post from June on Douyin, China’s version of TikTok, read: “Breaking news: China and the US engaged in 12 hours of cyber warfare, causing Luzon…
By Ankur Banerjee SINGAPORE (Reuters) – Asian stocks got a lift on Thursday from Chinese stocks as China’s central bank kicked off its 500 billion yuan facility to spur capital markets, while the dollar lingered near a two-month high ahead of U.S. inflation data later in the day. The People’s Bank of China (PBOC) said…
A look at the day ahead in European and global markets from Rae Wee Asian markets rallied on Thursday, defying weakness overnight on Wall Street as optimism over China’s latest stimulus measures got a fresh boost from news of a possible capital injection into its top banks. Authorities are considering a $142 billion infusion to…